Fewer Annual Deaths in Japan with Negative Excess Mortality for COVID-19 | Abstract

Asploro Journal of Biomedical and Clinical Case Reports

Asploro Journal of Biomedical and Clinical Case Reports [ISSN: 2582-0370]

ISSN: 2582-0370

Article Type: Commentary

DOI: 10.36502/2021/ASJBCCR.6234

Asp Biomed Clin Case Rep. 2021 Apr 06;4(1):84-87

Hiroshi Bando1,2*
1Tokushima University/Medical Research, Tokushima, Japan
2Integrative Medicine Japan (IMJ), Shikoku Island Division, Tokushima, Japan

Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ORCID iD
Address: Tokushima University/Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 18 March 2021; Accepted date: 29 March 2021; Published date: 06 April 2021

Citation: Bando H. Fewer Annual Deaths in Japan with Negative Excess Mortality for COVID-19. Asp Biomed Clin Case Rep. 2021 Apr 06;4(1):84-87.

Copyright © 2021 Bando H. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

Keywords: COVID-19, Excess Mortality, Years of Life Lost, Ministry of Health, Labour and Welfare, Japan

Abbreviations: YLL: Years of Life Lost; MHLW: Ministry of Health, Labour and Welfare

Abstract

The excess mortality would be adequate objective indicator for COVID-19 research, and was reported in 77 countries for 2020. Several representative data are: United States 420,000, Mexico 270,000, Russia 270,000, Brazil 170,000, Japan -15,000, Taiwan -4,800, Australia -4,700 and New Zealand -2,100. From demographics in Japan, the number of deaths increased by 18 thousand each year during 2015-2019. However, death in 2020 decreased by 9,373 from 2019, which indicated 27 thousand difference. A meaningful perspective showed that focusing on human life saves the economy. Future crucial factors would be new ways of working with the ability of human resources.

asploro

Asploro Open Access Publications Limited